Ceribell (CBLL) Equity Ratio (2023 - 2026)

Ceribell (CBLL) reported Equity Ratio of 0.79 for Q1 2026, down 6.68% on a YoY basis from 0.85 in Q1 2025, and little changed quarter-over-quarter from 0.79 in Q4 2025.

Ceribell (CBLL) Equity Ratio (2023 - 2026) Analysis & Trends

Ceribell has reported Equity Ratio for 4 years, with the latest figure at 0.79 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio fell 6.68% year-over-year to 0.79; the trailing twelve-month figure through Mar 2026 stood at 0.79 (down 6.68% YoY), and the FY2025 full-year result was 0.79, down 6.45% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.79, roughly flat from 0.79 in the prior quarter.
  • The five-year high for Equity Ratio was 0.85 in Q4 2024, with the low at 2.89 in Q3 2024.
  • Historically, Equity Ratio has averaged 0.02 across 4 years, with a median of 0.81 in 2025.
  • Annual changes were most pronounced in 2024 — Equity Ratio surged 144.52% — and 2026, when it slipped 6.68%.
  • Ceribell's Equity Ratio stood at 1.91 in 2023, then surged by 144.52% to 0.85 in 2024, then declined by 6.45% to 0.79 in 2025, then declined by 0.33% to 0.79 in 2026.
  • The last three Equity Ratio figures came in at 0.79 (Q1 2026), 0.79 (Q4 2025), and 0.82 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 0.47
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 0.50
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 0.54
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 0.78
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 0.29
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.42
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 0.45
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 0.67
10 Ceribell 695.83 Mn 554.65 Mn 23.12 Mn 0.79

Historic Data

Download Data
DateValue
Mar 31, 2026 0.79
Dec 31, 2025 0.79
Sep 30, 2025 0.82
Jun 30, 2025 0.83
Mar 31, 2025 0.85
Dec 31, 2024 0.85
Sep 30, 2024 -2.89
Dec 31, 2023 -1.91